Recent advancements in biosensor design and sensing effectiveness should be integrated with research on responsive drug delivery systems to enhance health management and ensure patient compliance. Many illnesses require continuous monitoring to enable timely intervention. Physicochemical changes in the body can indicate the onset of illness before symptoms appear. Despite diagnostic and prognostic biosensors, medical interventions still face challenges. Delayed detection can reduce therapeutic efficacy, and conventional treatments may cause side effects such as tissue damage and hepatic and renal toxicity. Drug delivery systems offer a way to minimize side effects and improve patient adherence. Chronic illnesses necessitate ongoing monitoring and effective treatment strategiesStrategies. Designing responsive systems that react to physicochemical changes can enhance therapeutic outcomes. Integrating biosensors with drug delivery in implantable closed-loop systems allows for timely therapeutic interventions triggered by illness biomarkers. Proper biomarker selection is crucial for accurate diagnosis and effective responsive drug delivery. Detecting illness early based on biomarker levels can tailor therapeutic dosing to the severity of physiological changes. This review explores various biosensors and drug delivery systems, highlighting challenges and future prospects for their integration in detecting and managing chronic illnesses.